Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Jan 2.
Published in final edited form as: Immunity. 2017 Nov 21;47(5):1004. doi: 10.1016/j.immuni.2017.10.012

Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development

Raiees Andrabi, Ching-Yao Su, Chi-Hui Liang, Sachin S Shivatare, Bryan Briney, James E Voss, Salar Khan Nawazi, Chung-Yi Wu, Chi-Huey Wong, Dennis R Burton *
PMCID: PMC5749209  NIHMSID: NIHMS922587  PMID: 29166578

(Immunity 47, 524–537; September 19, 2017)

The authors inadvertently omitted some text from the legend for Figure 4B, making it difficult to interpret the figure. The full and complete legend appears here and online. The authors regret this omission.

(B) Octet binding curves (association: 120 s [180–300] and dissociation: 240 s [300–540]) of CAP256.21 and CAP256.25 Abs with CRF250 trimer, its individual glycan site-eliminated variants and their corresponding a2,6 desialylated versions. The binding curves for the WT CRF250 trimer and each of the glycan variants are depicted in different colors, whereas the responses for the desialylated trimer forms are all shown in red. The binding response of CAP256.25 bnAb with the CRF250 N156A variant is fixed to 0.2 nanometer (nm) for clarity.

RESOURCES